Concepedia

Author

B. Björkstrand

Karolinska Institutet

Also Known As

B Bjorkstrand, B Björkstrand, B. Bjorkstrand, B. Björkstrand, Bo BJÖrkstrand, Bo Björkstrand

22

Publications

2.2K

Citations

14

H-Index

26

Concepts

All Affiliations

Karolinska InstitutetKarolinska University HospitalHeidelberg UniversityUppsala University HospitalLeipzig University
BB

About

B. Björkstrand is an author at Karolinska Institutet specializing in medicine, hematology, and transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

225

2

Health Sciences

2

2

56

3

Blood Transplantation

2

2

36

4

Cellular Therapies

1

1

48

5

Hepatology

1

1

30

B. Björkstrand

×

16

Publications

2.2K

Citations

14

H-Index

YearCitations

CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION

Joan Bladé, Diana Samson, Donna Reece,

British Journal of Haematology

1998

1.5K

Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT).

Norbert Claude Gorin, Myriam Labopin, Giovanna Meloni,

PubMed

1991

132

Primary plasma cell leukemia and autologous stem cell transplantation

M. B. Drake, Stefano Iacobelli, Anja van Biezen,

Haematologica

2010

101

Suicide gene therapy for plasma cell tumors

M. Siraç Dilber, MR Abedi, B. Björkstrand,

Blood

1996

63

Prognostic Factors in Autologous Stem Cell Transplantation for Multiple Myeloma: An EBMT Registry Study

B. Björkstrand, A. H. Goldstone, Per Ljungman,

Leukemia & lymphoma/Leukemia and lymphoma

1994

61

Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized, controlled study

Per Ljungman, H Hägglund, B. Björkstrand,

Supportive Care in Cancer

1997

55

Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study

JH Bourhis, Yasmina Bouko, S. Koscielny,

Haematologica

2007

55

Tetanus immunity in autologous bone marrow and blood stem cell transplant recipients

Viera Hammarström, Karlis Pauksen, B. Björkstrand,

Bone Marrow Transplantation

1998

48

Autologous bone marrow transplantation for low-grade non-Hodgkin's lymphoma: The European Bone Marrow Transplant Group experience

Harry C. Schouten, P Colombat, Leo F. Verdonck,

Annals of Oncology

1994

43

Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma

Gösta Gahrton, S. Iacobelli, Giuseppe Bandini,

Haematologica

2007

36

Page 1